Beijing Tongrentang Co., Ltd (SHA:600085)

Market Cap	31.69B -39.2%
Revenue (ttm)	16.64B -10.5%
Net Income	1.08B -29.6%
EPS	0.79 -29.7%
Shares Out	1.37B
PE Ratio	29.40
Forward PE	21.01
Dividend	1.00 (4.25%)
Ex-Dividend Date	Jul 1, 2026

Volume	6,010,716
Open	22.70
Previous Close	23.11
Day's Range	22.61 - 23.26
52-Week Range	21.87 - 37.57
Beta	0.14
Analysts	Buy
Price Target	35.13 (+51.55%)
Earnings Date	Aug 31, 2026

About Beijing Tongrentang

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverag...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1997
• Employees: 17,284
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600085

Financial Performance

In 2025, Beijing Tongrentang's revenue was 17.26 billion, a decrease of -7.21% compared to the previous year's 18.60 billion. Earnings were 1.19 billion, a decrease of -22.07%.

Analyst Summary

According to 6 analysts, the average rating for 600085 stock is "Buy." The 12-month stock price target is ¥35.13, which is an increase of 51.55% from the latest price.

Price Target

¥35.13

(51.55% upside)

Analyst Consensus: Buy

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 1, 2026

Data Sources Report a data error